Barber Daniel 4

What Happened

• Daniel Barber, President and CEO of Aquestive Therapeutics (AQST), had 335,922 shares withheld by the company to satisfy his tax withholding obligation related to the vesting of Performance Stock Units (PSUs). The withholding is reported as a disposition (code F) at $4.18 per share, totaling approximately $1,404,154.
• This was a tax-withholding action on vested equity, not an open-market sale or a purchase.

Key Details

• Transaction date: 2026-05-05; Form 4 filed: 2026-05-07 (filed timely).
• Price and amount: 335,922 shares withheld at $4.18/share = ~$1,404,154.
• Post-transaction holdings: Not specified in the provided filing summary.
• Footnote: F1 — shares were withheld by the issuer to satisfy the Reporting Person’s tax withholding obligation in connection with the vesting of certain PSUs.
• Transaction code F indicates tax withholding (not a market sale).

Context

• Withholding shares to cover taxes is a routine administrative step when equity awards vest and does not necessarily reflect the insider’s view of the company’s prospects. It reduces the insider’s outstanding share count but is not a transfer to an external buyer.